What were the most commonly reported adverse reactions in pooled clinical trial safety data for cinnarizine (Stugeron)?

In pooled clinical trial safety data for cinnarizine (Stugeron), the most commonly reported adverse reactions, with incidence above 1%, were somnolence (9.9%) and increased weight (1.5%).